Top of the morning to you. Another shiny day is unfolding over the Pharmalot corporate campus, where we are recovering from moderating a panel at the big DIA show. To celebrate our survival, yes, we are quaffing a delicious cup of stimulation and invite you to join us. Speaking of which, we are hosting a webinar tomorrow on Healthcare Payers and Players at 1 pm ET, so please to tune in (
see this). Meanwhile, here is the usual line-up of tidbits. Have a great day and keep us in mind if you hear anything interesting.Merck To Continue Recording Revenue From AstraZeneca Deal (Reuters)
Senate Passes PDUFA Bill (Washington Post)
Covance To Add 465 Jobs To Indiana Site (Daily Journal)
Public Citizen Urges FDA To Reject Arena Diet Drug (Reuters)
Merck To Cut 30 Jobs At Pennsylvania Plant (Daily Item)
AMAG Closes Manufacturing Plant And Cuts 45 Jobs (Outsourcing Pharma)
Daiichi Sankyo To Open Pennsylvania Packaging Plant (Star-Ledger of NJ)
Irish Drug Price Deal Allows New Listings (Pharma Times)
Merck Serono And Compugen Establish Biomarker Company (Globes)
EDITOR'S NOTE: Please check this post for updates during the day
2 Comments
Rest up -- and here are two items, with some deeper (exclusive) original financial analyses -- of the Astra-Zeneca/Merck Nexium® extension, and the Cherokee plant layoffs items.
Namaste